These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 32732370)

  • 1. Global prevalence of Barrett's oesophagus and oesophageal cancer in individuals with gastro-oesophageal reflux: a systematic review and meta-analysis.
    Eusebi LH; Cirota GG; Zagari RM; Ford AC
    Gut; 2021 Mar; 70(3):456-463. PubMed ID: 32732370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review with meta-analysis: risk factors for Barrett's oesophagus in individuals with gastro-oesophageal reflux symptoms.
    Eusebi LH; Telese A; Cirota GG; Haidry R; Zagari RM; Bazzoli F; Ford AC
    Aliment Pharmacol Ther; 2021 May; 53(9):968-976. PubMed ID: 33705573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and prevention of oesophageal adenocarcinoma.
    Ness-Jensen E
    Scand J Gastroenterol; 2022 Aug; 57(8):891-895. PubMed ID: 35234549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
    Solaymani-Dodaran M; Logan RF; West J; Card T; Coupland C
    Gut; 2004 Aug; 53(8):1070-4. PubMed ID: 15247170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: Barrett's oesophagus and carcinoma in Japan.
    Hongo M
    Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():50-4. PubMed ID: 15575874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adam, Eve and the reflux enigma: age and sex differences across the gastro-oesophageal reflux spectrum.
    Royston C; Bardhan KD
    Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):634-639. PubMed ID: 28151751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal trends of Barrett's oesophagus and gastro-oesophageal reflux and related oesophageal cancer over a 10-year period in England and Wales and associated proton pump inhibitor and H2RA prescriptions: a GPRD study.
    Alexandropoulou K; van Vlymen J; Reid F; Poullis A; Kang JY
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):15-21. PubMed ID: 23022985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study.
    Anderson LA; Watson RG; Murphy SJ; Johnston BT; Comber H; Mc Guigan J; Reynolds JV; Murray LJ
    World J Gastroenterol; 2007 Mar; 13(10):1585-94. PubMed ID: 17461453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant Barrett's oesophagus.
    Li H
    Eur J Cancer Prev; 1993 Jan; 2(1):47-52. PubMed ID: 8428176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenocarcinoma and Barrett's oesophagus. A clinico-pathological study.
    Moghissi K; Sharpe DA; Pender D
    Eur J Cardiothorac Surg; 1993; 7(3):126-31. PubMed ID: 8461144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barrett's oesophagus: Current controversies.
    Amadi C; Gatenby P
    World J Gastroenterol; 2017 Jul; 23(28):5051-5067. PubMed ID: 28811703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution and outcome of surveillance of Barrett's oesophagus over four decades in a UK District General Hospital.
    Royston C; Caygill C; Charlett A; Bardhan KD
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1365-1373. PubMed ID: 27571366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barrett's oesophagus and carcinoma. Recent insights into its development and possible prevention.
    Peters FT; Kleibeuker JH
    Scand J Gastroenterol Suppl; 1993; 200():59-64. PubMed ID: 8016573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma.
    Lord RV; Frommer DJ; Inder S; Tran D; Ward RL
    Aust N Z J Surg; 2000 Jan; 70(1):26-33. PubMed ID: 10696939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic biomarkers in progression from non-dysplastic Barrett's oesophagus to oesophageal adenocarcinoma: a systematic review protocol.
    Nieto T; Tomlinson CL; Dretzke J; Bayliss S; Dilworth M; Beggs AD; Tucker O
    BMJ Open; 2016 Dec; 6(12):e013361. PubMed ID: 27927666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review: Barrett's oesophagus in Taiwan.
    Chen PH
    J Gastroenterol Hepatol; 1997 Jun; 12(6):S19-22. PubMed ID: 9195407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of gastro-esophageal reflux symptoms on the risk of Barrett's esophagus: A systematic review and meta-analysis.
    Eusebi LH; Telese A; Cirota GG; Haidry R; Zagari RM; Bazzoli F; Ford AC
    J Gastroenterol Hepatol; 2022 Aug; 37(8):1507-1516. PubMed ID: 35614860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review with meta-analysis: prevalent vs. incident oesophageal adenocarcinoma and high-grade dysplasia in Barrett's oesophagus.
    Visrodia K; Singh S; Krishnamoorthi R; Ahlquist DA; Wang KK; Iyer PG; Katzka DA
    Aliment Pharmacol Ther; 2016 Oct; 44(8):775-84. PubMed ID: 27562355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenocarcinoma risk in patients registered with Polish Barrett's Oesophagus Registry.
    Januszewicz W; Kaminski MF; Wieszczy P; Wronska E; Bielasik A; Wojciechowska U; Didkowska J; Orlowska J; Regula J
    Dis Esophagus; 2017 Jan; 30(1):1-6. PubMed ID: 27377059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.